| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Sep―09 |
Molecular characterization and antifungal susceptibility of
Aspergillus
spp. isolated from critically ill COVID-19 patients: implications for suspected COVID-19-associated pulmonary aspergillosis (CAPA) in a Brazilian tertiary referral hospital |
Tiago Alexandre Cocio, Vivian Caso Coelho, Ludmilla Tonani, Ingrid Gonçalves Costa - Leite, Marcia Regina von Zeska Kress, Gilda Maria Barbaro Del Negro, Marcia de Souza Carvalho Melhem, Célia Soares, Nelson Lima, Tânia Sueli de Andrade, Marcello Mihailenko Chaves Magri, Gil Benard, Roberto Martinez, Valdes Roberto Bollela |
| 2 |
[GO] |
2026―Aug―29 |
Kinetics of anti-
Aspergillus
spp. IgG antibodies in COVID-19-associated pulmonary aspergillosis |
Camille Cordier, Chloë Lemaire, Fanny Vuotto, Mahdi Ouafi, Séverine Loridant, Gaetan Piga, Jordan Leroy, Julien Poissy, Boualem Sendid, Anahita Rouzé, Marjorie Cornu |
| 3 |
[GO] |
2026―Jul―31 |
Candidemia during the COVID-19 pandemic in a Brazilian tertiary care hospital: comparison of episodes with and without COVID-19 |
Debora Otero Britto Passos Pinheiro, Anna Carla Castiñeiras, Luiz Felipe Abreu Guimarães, Gloria Barreiros, Henrique Leandro Reis Rocha, Marcio Nucci, Simone A Nouér |
| 4 |
[GO] |
2025―Nov―04 |
Impact of COVID-19 on Candidemia: Risk Factors and Outcomes in a Southeastern U.S. Cohort |
Melat Endashaw, Austin Dykes, Rachael Clark, Laila Warrayat, McKenzie J Hodges, Shiyuan Deng, Xianyan Chen, Andrés F Henao-Martínez, Daniel B Chastain |
| 5 |
[GO] |
2025―Jul―20 |
Statistical Analysis of Pulmonary Mycosis in a Tertiary Hospital in Eastern China before and after the Pandemic of COVID-19 |
Gege Cao, Ran Wang, Qingtian Hu, Yong Zhang, Desheng Wu |
| 6 |
[GO] |
2025―Apr―08 |
KL-6 as a Predictor of Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis (CAPA) and Mortality in Critically Ill Covid-19 Patients: A Single-Center Retrospective Cohort Study |
Hyun Kyu Cho, Si-Ho Kim, Cheon-Hoo Jeon, Jae Wan Jung, Yu Mi Wi |
| 7 |
[GO] |
2025―Mar―06 |
COVID-19-associated invasive fungal infections in intensive care unit patients during the first pandemic waves in Argentina: Results of a single center experience |
Gladys Beatriz Posse, Fernanda Mariel Barberis, María Fernanda Benedetti, Daniel Pezzola, Katherine Hermida Alava, Carolina Rodríguez Laboccetta, Agustín Videla Garrido, Víctor Fernández Briceño, Paula Capece, Alejandro Nusblat, María Luján Cuestas |
| 8 |
[GO] |
2025―Mar―06 |
COVID-19 Associated Pulmonary Aspergillosis in a Tertiary Care Center in the Midwestern Region of Brazil CAPA in a Hospital in Brazil |
Marina Miranda Ely, Andyane Freitas Tetila, Anamaria Mello Miranda Paniago, Luana Rossato |
| 9 |
[GO] |
2025―Jan―14 |
The impact of the COVID-19 on the antifungal consumption and antifungal resistance in Candida species isolated from the blood cultures of critically ill patients in intensive care units |
Emre Kara, Gokhan Metan, Dolunay Gülmez, Sevtap Arikan-Akdagli |
| 10 |
[GO] |
2024―Aug―02 |
Correction to: Comparison of Candida colonization in intensive care unit patients with and without COVID-19: First prospective cohort study from Turkey |
|
| 11 |
[GO] |
2024―Jul―09 |
Epidemiology of candidemia during COVID-19 pandemic era in a teaching hospital: A non-concurrent cohort study |
Flávio Pasa Brandt, Jonas Atique Sawazaki, Ricardo de Souza Cavalcante |
| 12 |
[GO] |
2024―Jun―23 |
Factors Influencing Mortality in COVID-19-Associated Mucormycosis - The International ID-IRI Study |
Meyha Sahin, Mesut Yilmaz, Ali Mert, Behrouz Naghili, Fatemeh Ravanbakhsh, Mojtaba Varshochi, Ilad Alavi Darazam, Mohammad Javad Ebrahimi, Maral Moafi, Hamed Azhdari Tehrani, Amjad Mahboob, Naveed Rashid, Ejaz Ahmed Khan, Atousa Hakamifard, Gülden Eser-Karlidag, Abdolreza Babamahmoodi, Amani El-Kholy, Sayed Hussain Mosawi, Ayşe Albayrak, Jamal Wadi Al Ramahi, Syam Kumar Addepalli, Şafak Özer Balin, Asfandiyar Khan, Nirav Pandya, Esra Gurbuz, Gülden Sincan, Hadia Azami, Rıdvan Dumlu, Reham Khedr, Rezaul Karim Ripon, Sevil Alkan, Şükran Kose, Bahadır Ceylan, Hakan Erdem |
| 13 |
[GO] |
2024―Apr―08 |
Comparison of Candida colonization in intensive care unit patients with and without COVID-19: First prospective cohort study from Turkey |
Ilvana Çaklovica Küçükkaya, Günseli Orhun, Arif Atahan Çağatay, Sadık Kalaycı, Figen Esen, Fikrettin Şahin, Ali Ağaçfidan, Zayre Erturan |
| 14 |
[GO] |
2024―Mar―28 |
Prospective and systematic screening for invasive aspergillosis in the ICU during the COVID-19 pandemic, a proof of principle for future pandemics |
Rebecca van Grootveld, Judith van Paassen, Eric C J Claas, Laura Heerdink, Ed J Kuijper, Mark G J de Boer, Martha T van der Beek |
| 15 |
[GO] |
2024―Mar―13 |
Revealing the hidden interplay: the unexplored relationship between fungi and viruses beyond HIV, SARS-CoV-2 and influenza |
Théo Ghelfenstein-Ferreira, Alexandra Serris, Maud Salmona, Fanny Lanternier, Alexandre Alanio |
| 16 |
[GO] |
2023―Dec―22 |
Predicting Intracranial Involvement: Unveiling Perineural Spread in COVID-19-Associated Mucormycosis, a Novel Phenomenon |
Nidhin Das K, Vidhu Sharma, Diksha Gupta, Sarbesh Tiwari, Poonam Elhence, Vidhi Jain, Kapil Soni, Amit Goyal |
| 17 |
[GO] |
2023―Sep―13 |
Diagnosis of mucormycosis using a simple duplex PCR assay: analysis of 160 clinical samples from COVID-19 patients |
Shima Aboutalebian, Mahzad Erami, Amir Hossein Ahsaniarani, Mansooreh Momen-Heravi, Alireza Sharif, Mahboubeh Hadipour, Hossein Mirhendi |
| 18 |
[GO] |
2023―Aug―22 |
Percentage of Th1 and Th17 Cells and Serum Level of IL-17 and IFN-γ cytokines in COVID-19-associated Mucormycosis |
Narjes Soleimanifar, Sara Assadiasl, Abdolrahman Rostamian, Alireza Abdollahi, Mohammadreza Salehi, Mohsen Abdolmaleki, Saeed Barzegari, Abolfazl Sobati, Maryam Sadr, Bahareh Mohebbi, Hanieh Mojtahedi, Mohammad Hossein Nicknam |
| 19 |
[GO] |
2023―Jul―14 |
Yeasts from blood cultures in the wake of the COVID-19 pandemic in a tertiary care hospital: Shift in species epidemiology, steady low antifungal resistance and full in vitro ibrexafungerp activity |
Judith Díaz-García, Aina Mesquida, Marina Machado, Carlos Sánchez-Carrillo, Patricia Muñoz, Pilar Escribano, Jesús Guinea |
| 20 |
[GO] |
2023―Jun―08 |
Evidence of anti-Hcp100 antibodies in COVID-19 critically ill patients with detectable anti-histoplasmin antibodies in a highly endemic area for histoplasmosis |
María A Toscanini, Fernanda Barberis, Fernanda Benedetti, Carolina Rodríguez Laboccetta, Agustín Videla Garrido, Víctor Fernández Briceño, Gladys B Posse, Paula Capece, Alejandro D Nusblat, María L Cuestas |
| 21 |
[GO] |
2023―Jun―08 |
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis-a two-centre observational study |
Rahul Costa-Pinto, Sarah Klink, Hannah Rotherham, Padeepa Perera, Liam Finlay, Karen Urbancic, Karl Vaz, Jason Trubiano, Rinaldo Bellomo |
| 22 |
[GO] |
2023―Mar―12 |
Microbial and clinical epidemiology of invasive fungal rhinosinusitis in hospitalized COVID-19 patients, the divergent causative agents |
Mahzad Erami, Shima Aboutalebian, Seyed Jamal Hashemi Hezaveh, Roshanak Daie Ghazvini, Mansooreh Momen-Heravi, Yazdan Jafari, Amir Hossein Ahsaniarani, Bahare Basirpour, Amir Hassan Matini, Hossein Mirhendi |
| 23 |
[GO] |
2022―Dec―08 |
Can bronchial secretion cultures identify the etiologic agent of COVID-19-associated pulmonary aspergillosis in ICU patients? Comparison with a species-specific Aspergillus PCR in serum |
Maria Siopi, Stavroula Antonopoulou, Paraskevi Mantzana, Panagiota-Christina Georgiou, Sophia Vourli, Efthymia Protonotariou, Eleni Vagiakou, Lemonia Skoura, Spyros Pournaras, Joseph Meletiadis |
| 24 |
[GO] |
2022―Sep―20 |
P313 A retrospective analysis of COVID-19 - associated Mucormycosis in a tertiary care center in Northern India |
Sukriti Yadav, Ishani Bora, Gursimran Kaur Mohi, M R Shivaprakash, Mini P Singh, R K Ratho, Manjul Muralidharan |
| 25 |
[GO] |
2022―Sep―20 |
P155 A Mexican case series of COVID-19 - associated pulmonary aspergillosis |
Diana Perales-Martinez, Jesus Ruiz-Quiñones, Corazón de Jesús Barrientos-Flores, Daniel Aguilar-zapata |
| 26 |
[GO] |
2022―Sep―20 |
P182 Mucormycosis in Northwest Iranian cases with a history of delta COVID-19, a brief report |
Kambiz Diba, Reza Samarei, Rahim Nejadrahim, Atefeh Namaki |
| 27 |
[GO] |
2022―Sep―20 |
P189 The effect of COVID-19 and immunosuppressive drugs and diabetes on the spread of mucomycosis |
Maryam Esfidani |
| 28 |
[GO] |
2022―Sep―20 |
P184 Candida auris candidemia in COVID-19 and post-COVID-19 patients in a tertiary care hospital in North India |
Ajai Kumar Dixit, Rungmei S. K. Marak, Chitra Bhartiya, Afzal Azim, Chinmoy Sahu, Shikha Tripathi |
| 29 |
[GO] |
2022―Sep―20 |
P173 PK PD rationale and efficacy of isavuconazole treatment after failure of amphotericin B and posaconazole for COVID-19 associated cranial Mucormycosis |
Rajeev Soman, Sourabh Chakraborty, Geethu Joe, Bharat Purandare, Rasika Joshi, Sampada Patwardhan |
| 30 |
[GO] |
2022―Sep―20 |
P170 Life threatening hemoptysis in COVID-19 associated Pulmonary Aspergillosis (CAPA) |
Rajeev Soman, Sourabh Chakraborty, Vineet Rao, Shailesh Rohit, Geethu Joe |
| 31 |
[GO] |
2022―Sep―20 |
P183 Monitoring of candida colonization in the respiratory tract of COVID-19 cases |
Kambiz Diba, Khadige Makhdoomi, Rahim Nejadrahim, Atefeh Namaki |
| 32 |
[GO] |
2022―Sep―20 |
P442 Bacterial and fungal infection in COVID-19 diagnosed cases in a tertiary care ICU setting in the wake of second wave in Kolkata, India |
Soumyadeep Seal, Dip Narayan Mukherjee |
| 33 |
[GO] |
2022―Sep―20 |
P211 Fungal and bacterial co-infections of the respiratory tract among patients with COVID-19 hospitalized in intensive care units |
Hasti Kamali Sarvestani, Mahmoud Khansari, Zahra Rafat, Alireza Abdollahi |
| 34 |
[GO] |
2022―Sep―20 |
P334 Fungal infections in patients with COVID-19 in 1-year pandemic 2020-2021 from Cote d'Ivoire |
David Koffi, Andre Toure, Valerie Ira, M. Francis Kouadjo, Reine M'boh, Karidia Sylla, Mireille Dosso |
| 35 |
[GO] |
2022―Sep―20 |
P156 Oral Candidiasis among inpatients with COVID-19 in the North of Iran |
Fatemeh Ahangarkani, Farhang Babamahmoodi, Mohammad Sadegh Rezai, Ali Mohammadi-Kali, Narges Najafi, Reza Alizadeh-Navaei, Hamid Badali |
| 36 |
[GO] |
2022―Sep―20 |
P135 Immunological correlation with clinicomycological aspects of fungal rhinosinusitis during COVID-19 pandemic |
Mohan Vashistha |
| 37 |
[GO] |
2022―Sep―20 |
P262 Clinico- microbiological profile of post-COVID pulmonary fungal infections encountered during the second wave of COVID-19 pandemic at a tertiary care teaching hospital in the Himalayas |
Oshin Puri, Mohit Bhatia, U Sasi Rekha, Deepika Chakraborty, Ruchi Dua, Minakshi Dhar, Udit Chauhan, Amber Prasad, Deepjyoti Kalita, Neelam Kaistha |
| 38 |
[GO] |
2022―Sep―20 |
P159 The impact of COVID-19 pandemic on invasive Candida auris infections in Kuwait |
Faten Al-Wathiqi, Alaa Alabdallah, Khaled Alobaid |
| 39 |
[GO] |
2022―Sep―20 |
P430 Correlation of microscopy and culture findings with serum ferritin level for the diagnosis of rhino-orbito-cerebral Mucormycosis during COVID-19 pandemic-a study from tertiary care hospital India |
Jothisri Lakshmanan, Shukla Das, Narendra Pal Singh |
| 40 |
[GO] |
2022―Sep―20 |
P263 Invasive Pulmonary Aspergillosis (IPA) Among Non-Intubated COVID-19 Patients-a New Age Fungal Storm |
Raghapriya Raghu, Jayanthi Savio |
| 41 |
[GO] |
2022―Sep―20 |
S1.1d Risk factors associated with oropharyngeal candidiasis in COVID-19 patients: a case control study |
Mohammadreza Salehi, Reyhaneh Sadat Kiyaei, Sadegh Khodavaisy, Nasim Khajavirad, Seyed Ali Dehghan Manshadi, Ilad Alavi Darazam, Arash Seifi |
| 42 |
[GO] |
2022―Sep―20 |
P282 Bacterial co-infections in Mucormycosis infected COVID-19 patients: experience from a tertiary care center in India |
Neha Sharad, Smriti Srivastava, Aparna Ningombam, Vandana Kiro, Sharin Varma, Sharad Srivastav, Rajesh Malhotra, Purva Mathur |
| 43 |
[GO] |
2022―Sep―20 |
P291 Aspergillosis: another force to reckon with during COVID-19 times |
Nidhi Singla, Surinder Singhal, Deepak Aggarwal, Varinder Saini, Varsha Gupta |
| 44 |
[GO] |
2022―Sep―20 |
P365 Upsurge of Mucormycosis in COVID-19-a retrospective study in a tertiary care hospital in Punjab |
Sangeetha Mohan |
| 45 |
[GO] |
2022―Sep―20 |
P233 COVID-19-a ssociated Mucormycosis: an experience of invasive fungal sinusitis from a tertiary care referral center in Northern India |
Rungmei S K Marak, Radhika Chaudhary, Amit Kumar Keshri, Surendra Singh Baghel, Ravi Sankar Manogaran, Ajai Kumar Dixit, Prabhakar Mishra |
| 46 |
[GO] |
2022―Sep―20 |
P163 Successful management of COVID-19-associated mucormycosis in state of pernambuco, northestearn brazil: 2 case reports |
Filipe Batista, Eduardo Araújo, Daniela Takano, Claudia Ferraz, Carolina Guerra, Tiago Ferraz, Renata Batista, Camila Batista, Reginaldo Lima Neto |
| 47 |
[GO] |
2022―Sep―20 |
P338 Clinicopathologic analysis of COVID-19-associated mucormycosis-experience from a tertiary care center in north india |
Arupparna Sengupta, Sunayana Misra, Shashi Dhawan, Sonia Badwal |
| 48 |
[GO] |
2022―Sep―20 |
P446 Molecular detection of fungal agents responsible for COVID-19-associated mycosis directly from tissue specimens |
Vikramjeet Singh, Anupam Das, Ashish Chandra Agarwal, Nikhil Gupta, Manodeep Sen, Jyotsna Agarwal |
| 49 |
[GO] |
2022―Sep―20 |
P424 Comparative analysis of Galactomannan Lateral Flow Assay, Galactomannan Enzyme Immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis |
Mohammad Hedayati, Mona Ghazanfari, Jamshid Yazdani Charati, Lotfollah Davoodi, Amir Arastehfar, Maryam Moazeni, Mahdi Abastabar, Iman Haghani, Sabah Mayahi, Martin Hoenigl, Weihua Pan |
| 50 |
[GO] |
2022―Sep―20 |
S3.3d Influenza versus COVID-19-associated pulmonary aspergillosis: Profiling lower respiratory tract epithelial and myeloid innate immunity in patient samples |
Simon Feys, Samuel M. Gonçalves, Mona Khan, Sumin Choi, Bram Boeckx, Denis Chatelain, Cristina Cunha, Yves Debaveye, Greet Hermans, Marjan Hertoghs, Stephanie Humblet-Baron, Cato Jacobs, Katrien Lagrou, Lukas Marcelis, Julien Maizel, Philippe Meersseman, Rémy Nyga, Laura Seldeslachts, Marick Rodrigues Starick, Karin Thevissen, Christophe Vandenbriele, Lore Vanderbeke, Greetje Vande Velde, Niels Van Regenmortel, Arno Vanstapel, Sam Vanmassenhove, Alexander Wilmer, Frank L. Van de Veerdonk, Gert De Hertogh, Peter Mombaerts, Diether Lambrechts, Agostinho Carvalho, Johan Van Weyenbergh, Joost Wauters |
| 51 |
[GO] |
2022―Sep―20 |
P398 COVID-19-associated pulmonary aspergillosis: Species distribution and susceptibility profiles |
Hamed Fakhim, Afsane vaezi, Elahe nasri, Somayeh Sadeghi, Mahsa Shelerangkon, Mahnaz Hosseini Rizi, Safiyeh Ghafel, Hamid Badali, Hossein Mirhendi |
| 52 |
[GO] |
2022―Sep―20 |
P494 Comparison of Candida
colonization in intensive care unit patients with and without COVID-19: First prospective cohort study from Turkey |
İlvana Çaklovica Küçükkaya, Günseli Orhun, Arif Atahan Çağatay, Sadık Kalaycı, Figen Esen, Fikrettin Şahin, Ali Ağaçfidan, Zayre Erturan |
| 53 |
[GO] |
2022―Sep―20 |
P168 Metastatic mo ld infections after COVID-19: the mo ld time -bomb |
Rajeev Soman, Sourabh Chakraborty, Geethu Joe, Bharat Purandare, Shweta Panchakshari, Sampada Patwardhan |
| 54 |
[GO] |
2022―Sep―20 |
P327 Prevalence of orofacial Mycoses in COVID-19patients: experience from a tertiary care center in Northern India |
Sonu Kumari Agrawal, Bansidar Tarai, Madhuri Somani |
| 55 |
[GO] |
2022―Sep―20 |
P193 Candidemia in coronavirus disease 2019 patients in a university hospital in Buenos Aires, Argentina |
Norma B. Fernandez, Luciana Farias, Stella Maris de Gregorio, Andrea Padovani, Monica Foccoli |
| 56 |
[GO] |
2022―Sep―20 |
S5.5d SARS-CoV-2 associated invasive fungal sinus infections; the Sri Lankan perspective |
H Thabrew, Liyanage Shamithra Madhumali Sigera, A P Anand, R A D M Ramanayake, Munasinghe M V, W L L N Wickramasekara, P I Jayasekera |
| 57 |
[GO] |
2022―Sep―20 |
P374 Fungal coinfection in patients with SARS-CoV-2: Atertiary care hospital study |
Vikas Saini, Gargi Rai, Praveen Singh, Shukla Das, Narendra Pal Singh |
| 58 |
[GO] |
2022―Sep―20 |
S1.4b Challenges in diagnosing and management of invasive fungal infections during the pandemic |
Methee Chayakulkeeree |
| 59 |
[GO] |
2022―Sep―20 |
P273 Diagnostic dilemmas in Pneumocystis pneumonia in case of long COVID -19 |
Arpit Shah |
| 60 |
[GO] |
2022―Aug―27 |
SARS-CoV-19-associated Rhino-orbital and cerebral Mucormycosis: Clinical and Radiological Presentations |
Ashima Mittal, Nitika Mahajan, Devinder Pal Singh Dhanota, Birinder S Paul, Srishti Ahluwalia, Saumya Ahluwalia, Arnav Galhotra, Veenu Gupta, Sanjeev Puri, Rohit Verma, Manish Munjal, Sahil Goel, Sumeet Chopra, Rajesh Mahajan, Archana Ahluwalia, Kavita Saggar, Gagandeep Singh |
| 61 |
[GO] |
2022―Jun―16 |
‘Risk factors for COVID-19 associated mucormycosis in India: A case control study.’ |
Atul K Patel, Harsh Bakshi, Kahaan Shah, Saloni Patel, Tushar Patel, Kamlesh Patel, Ketan K Patel |
| 62 |
[GO] |
2022―Apr―08 |
Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina |
Gustavo Giusiano, Norma B Fernández, Roxana G Vitale, Christian Alvarez, María Eugenia Ochiuzzi, Gabriela Santiso, Matías Sebastián Cabeza, Fernanda Tracogna, Luciana Farías, Javier Afeltra, Luciana María Noblega, Carla Valeria Giuliano, Guillermo Garcia-Effron |
| 63 |
[GO] |
2021―Nov―10 |
Clinical characteristics and risk factors for COVID-19-associated Candidemia |
Ali S Omrani, Junais Koleri, Fatma Ben Abid, Joanne Daghfal, Thasneem Odaippurath, Mohamed Zuhail Peediyakkal, Anas Baiou, Enas Sarsak, Mahmoud Elayana, Anvar Kaleeckal, Muna A Almaslamani |
|
